154 related articles for article (PubMed ID: 9667855)
1. SH2 and PTB domain interactions in tyrosine kinase signal transduction.
Shoelson SE
Curr Opin Chem Biol; 1997 Aug; 1(2):227-34. PubMed ID: 9667855
[TBL] [Abstract][Full Text] [Related]
2. SH2 and PTB domains in tyrosine kinase signaling.
Schlessinger J; Lemmon MA
Sci STKE; 2003 Jul; 2003(191):RE12. PubMed ID: 12865499
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.
Wagner MJ; Stacey MM; Liu BA; Pawson T
Cold Spring Harb Perspect Biol; 2013 Dec; 5(12):a008987. PubMed ID: 24296166
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
5. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
6. Src homology 2 domain-based high throughput assays for profiling downstream molecules in receptor tyrosine kinase pathways.
Yaoi T; Chamnongpol S; Jiang X; Li X
Mol Cell Proteomics; 2006 May; 5(5):959-68. PubMed ID: 16477079
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
[TBL] [Abstract][Full Text] [Related]
8. Affinity, specificity, and kinetics of the interaction of the SHC phosphotyrosine binding domain with asparagine-X-X-phosphotyrosine motifs of growth factor receptors.
Laminet AA; Apell G; Conroy L; Kavanaugh WM
J Biol Chem; 1996 Jan; 271(1):264-9. PubMed ID: 8550571
[TBL] [Abstract][Full Text] [Related]
9. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
10. Regulation and targets of receptor tyrosine kinases.
Pawson T
Eur J Cancer; 2002 Sep; 38 Suppl 5():S3-10. PubMed ID: 12528767
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions.
Hock B; Böhme B; Karn T; Feller S; Rübsamen-Waigmann H; Strebhardt K
Oncogene; 1998 Jul; 17(2):255-60. PubMed ID: 9674711
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
13. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
[TBL] [Abstract][Full Text] [Related]
14. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
[TBL] [Abstract][Full Text] [Related]
15. Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected.
Koytiger G; Kaushansky A; Gordus A; Rush J; Sorger PK; MacBeath G
Mol Cell Proteomics; 2013 May; 12(5):1204-13. PubMed ID: 23358503
[TBL] [Abstract][Full Text] [Related]
16. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
17. Sck interacts with KDR and Flt-1 via its SH2 domain.
Igarashi K; Shigeta K; Isohara T; Yamano T; Uno I
Biochem Biophys Res Commun; 1998 Oct; 251(1):77-82. PubMed ID: 9790910
[TBL] [Abstract][Full Text] [Related]
18. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains.
Zhou Y; Abagyan R
Fold Des; 1998; 3(6):513-22. PubMed ID: 9889165
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
[TBL] [Abstract][Full Text] [Related]
20. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.
Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O
J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
